Shao completed his PhD in Experimental Medicine at McGill University Health Center, focusing on regulatory B cells and follicular T cells. Prior to joining Dr. James Lee at UCSF, he did business internships in strategic planning and digital medicine at Becton Dickinson, Merck, and Embecta. Following the internships, he did his 1st postdoctoral fellowship at Stanford University Biodesign and Urology, focusing on finding medical/surgical needs and subsequently bringing them to prototyping. During his 1st postdoc, he completed Stanford Graduate School of Business Ignite Executive program in which he pitched our venture for a medical need to VCs for a potential startup. Shao was also a business consultant for Cancerandwork.ca, an organization helping cancer patients return back to work. The goal was to transform this organization to a for-profile company.

Shao dedicate his work as a postdoctoral fellow topre-clinical research in finding new therapeutic solutions for patients diagnosed with melanoma and liver metastasis. Specifically, we are looking into the gene GILZ and how this gene may immune-modulate host immune system in the tumor microenvironment. From this research, one of his major goals is to unveil how B cells can be targeted for tumor suppression.